End Date (year)
2021
Funding Organization
Announcement Type
Funding
Deadline Alternative Text
Applicants must submit a mandatory LOI to CIHR: March 15, 2021
Research Category
Internal Deadline
Body
This funding opportunity is part of Government of Canada's continued response to address the health challenges of the COVID-19 pandemic.
As the pandemic has evolved, so have the research needs of decision makers. There are important research gaps in Canada’s response that have become evident; gaps that need to be addressed rapidly and in a sustained manner to respond effectively to the pandemic. In order to achieve its goals, the Government of Canada will launch several funding opportunities under the “Emerging COVID-19 Research Gaps and Priorities” banner to address the identified research gaps in Canada. As priority gap areas are identified, additional funding opportunities will be launched. The purpose of this and upcoming funding opportunities is to provide rapid funding for projects which respond to identified gaps in COVID-19 research areas.
The specific objectives of this funding opportunity are to:
- Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and
- Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas as indicated here.
For more information please see the program description: https://www.
Funding
The maximum amount per grant that can be requested for a clinical trial or a randomized control trial is $1,000,000 over one year.
The maximum amount per grant that can be requested for all other types of research is $500,000 over one year.
Deadlines
Letter of Intent Stage
Applicants are required to submit a Letter of Intent (LOI) to CIHR using ResearchNet. No review process will be performed on the LOI.
Applicants are not required to submit their LOI to Research Services for review and signature; however, applicants are requested to send a copy of their LOI to lcudmore@upei.ca for information purposes.
Applicants must submit the LOI to CIHR using the ResearchNet system by the CIHR deadline: March 15, 2021
Application Stage
1) UPEI internal approval
Applicants must submit a penultimate copy of their application using the UPEI Romeo Researcher Portal and ensure that it reaches Research Services by April 12, 2021.
Applicants must submit a penultimate copy of their application using the UPEI Romeo Researcher Portal and ensure that it reaches Research Services by April 12, 2021.
Include the CIHR Signature Page as it requires the signature of the Vice President, Academic and Research.
2) CIHR Submission
Applicants must submit the application to CIHR using the ResearchNet system by the CIHR application deadline: April 15, 2021